Tenax Therapeutics announces pricing of $10 million underwritten offering
Tenax Therapeutics announced the pricing of an underwritten offering for gross proceeds o $10 million, prior to deducting underwriting discounts and commissions and offering expenses payable by Tenax. The offering is comprised of 5,181,346 units, priced at an offering price of $1.93 per unit. December 07, 2018